Whalegun
Home

Sanofi SNY paid Forbes-Tate $50K for lobbying in Q2 2023 · Medicare, Taxation and 1 more issue

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q2 2023
Stock
Sanofi SNY
Client
Sanofi U.S.
Reported
23/07/15

Up 0.0% from last quarter

What else happened in Sanofi around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Sanofi U.S.'s other lobbying reports

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 07/20

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 07/20

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 04/20

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 04/19

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 01/20

Sanofi SNY paid Forbes-Tate $50K for lobbying in Q2 2023 · Medicare, Taxation and 1 more issue | Whalegun